Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
20.93
+0.02 (0.07%)
Aug 17, 2026, 12:26 PM EDT - Market open
Amphastar Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Amphastar Pharmaceuticals stock has a consensus rating of "Hold" and an average price target of $22. The average 1-year stock price forecast is 5.14% higher than the current stock price, while the lowest is $20 (-4.42%) and the highest is $30 (+43.37%).
Price Target: $22 (+5.14%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Amphastar Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 4 | 5 | 7 | 6 | 6 | 6 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Maintains $20 | Hold | Maintains | $20 | -4.42% | Aug 7, 2026 |
| Piper Sandler | Piper Sandler | Hold Reiterates $21 → $20 | Hold | Reiterates | $21 → $20 | -4.42% | Aug 7, 2026 |
| Wells Fargo | Wells Fargo | Hold Reiterates $19 → $20 | Hold | Reiterates | $19 → $20 | -4.42% | Aug 7, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Reiterates $20 | Sell | Reiterates | $20 | -4.42% | Aug 7, 2026 |
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Hold Maintains $30 | Hold | Maintains | $30 | +43.37% | Jul 23, 2026 |
Financial Forecast
Revenue This Year
748.24M
from 719.89M
Increased by 3.94%
Revenue Next Year
756.37M
from 748.24M
Increased by 1.09%
EPS This Year
2.65
from 3.25
Decreased by -18.46%
EPS Next Year
2.61
from 2.65
Decreased by -1.51%
EPS and Forward PE are based on non-GAAP adjusted numbers.